Sign in

CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company

Eton Pharmaceuticals, Inc.

Sign in to watch
Ticker
ETON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371858472
Phone
(847) 787-7361
Business address
21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
  1. 4 Open-market sale Chief Commercial Officer sold 3,500 shares at an average $67.41 ($235,937)
  2. 4 Open-market sale Director sold 80,555 shares at an average $66.35 ($5,345,072)
  3. 4 Open-market sale Chief Business Officer sold 4,166 shares at $55.07 ($229,406)
  4. 4/A Open-market sale Director sold 50,000 shares at an average $59.07 ($2,953,572)
  5. 4 Open-market sale Director sold 50,000 shares at an average $59.07 ($2,953,572)
  6. 4 Open-market sale Chief Business Officer sold 25,000 shares at $65.07 ($1,626,750)
  7. 4 Open-market sale President & CEO sold 100,000 shares at an average $60.88 ($6,087,773)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4/A Open-market sale 10% owner sold 28,315 shares at $37.54 ($1,063,033)
  18. 4 Open-market sale 10% owner sold 28,315 shares at $37.54 ($1,063,033)
  19. 4 Option exercise President & CEO acquired 227,500 shares (option exercise)
  20. 4 Option exercise Chief Business Officer acquired 10,000 shares (option exercise)

Page 1 of 7 · 133 filings